Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease
Open accessAbstract
Liver biology and function, drug-induced liver injury (DILI) and liver diseases are difficult to study using current in vitro models such as primary human hepatocyte (PHH) monolayer cultures, as their rapid de-differentiation restricts their usefulness substantially. Thus, we have developed and extensively characterized an easily scalable 3D PHH spheroid system in chemically-defined, serum-free conditions. Using whole proteome analyses, we found that PHH spheroids cultured this way were similar to the liver in vivo and even retained their inter-individual variability. Furthermore, PHH spheroids remained phenotypically stable and retained morphology, viability, and hepatocyte-specific functions for culture periods of at least 5 weeks. We show that under chronic exposure, the sensitivity of the hepatocytes drastically increased and toxicity of a set of hepatotoxins was detected at clinically relevant concentrations. An interesting example was the chronic toxicity of fialuridine for which hepatotoxicity was mimicked after repeated-dosing in the PHH spheroid model, not possible to detect using previous in vitro systems. Additionally, we provide proof-of-principle that PHH spheroids can reflect liver pathologies such as cholestasis, steatosis and viral hepatitis. Combined, our results demonstrate that the PHH spheroid system presented here constitutes a versatile and promising in vitro system to study liver function, liver diseases, drug targets and long-term DILI.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Primary cells maintain essential tissue-level interactions, structural organization, and functional stability, critical for modeling drug penetration, systemic toxicity, and tissue-specific response.
“Furthermore, primary cells maintain essential tissue-level interactions, structural organization, and functional stability, which are critical for modeling drug penetration, systemic toxicity, and tissue-specific response (Bell et al. 2016).”
From Primary cell cultures versus immortalized cell lines: critical comparative insights into biological fidelity and translational applications (2026) · cites this paper as Bell et al. 2016
The Discussion (page unavailable) says that 3D primary human hepatocyte spheroids recapitulate aspects of liver structure and maintain liver-specific functions; the Results show their use in studying drug-induced liver injury. The claim extends those findings to primary cells generally. The passages do not establish that the model captures drug penetration or systemic toxicity. (LLM, conf=0.86)
Experimental — accuracy not yet measuredMultiple comparative studies indicate that spheroid cultures sustain elevated liver-specific functions such as albumin secretion, urea production, and drug-metabolizing enzyme activity, while demonstrating enhanced sensitivity to hepatotoxic compounds and a longer lifespan.
“Multiple comparative studies indicate that spheroid cultures sustain elevated liver-specific functions, such as albumin secretion, urea production, and drug-metabolizing enzyme activity, while simultaneously demonstrating enhanced sensitivity to hepatotoxic compounds and a longer lifespan [26,27].”
From The Hepatocyte Expansion Paradox: A Review of In Vitro Challenges and Advances (2026) · cites this paper as [26]
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredThree-dimensional (3D) spheroid hepatic cultures have emerged as promising tools to assess mechanisms of hepatotoxicity, as they demonstrate enhanced liver phenotype, metabolic activity, and stability in culture not attainable with conventional two-dimensional hepatic models.
“Three-dimensional (3D) spheroid hepatic cultures have emerged as promising tools to assess mechanisms of hepatotoxicity, as they demonstrate enhanced liver phenotype, metabolic activity, and stability in culture not attainable with conventional two-dimensional hepatic models.”
From Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury (2017) · cites this paper as Bell et al. 2016
Increased sensitivity of these models to drug-induced cytotoxicity has been demonstrated with relatively small panels of hepatotoxicants.
“Increased sensitivity of these models to drug-induced cytotoxicity has been demonstrated with relatively small panels of hepatotoxicants.”
From Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury (2017) · cites this paper as Bell et al. 2016
Prolonged drug exposure of up to 28 days resulted in increased sensitivity for detection of DILI compounds amiodarone, bosentan, diclofenac, fialuridine, and tolcapone.
“These data are in agreement with the findings of Bell et al. (2016) who noted prolonged drug exposure of up to 28 days resulted in increased sensitivity for detection of DILI compounds amiodarone, bosentan, diclofenac, fialuridine, and tolcapone (Bell et al. 2016).”
From Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury (2017) · cites this paper as Bell et al. 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Glutathione Metabolism and Its Implications for Health
Wu, G., Lupton, J. R., Turner, N. D., Fang, Y.-Z., & Yang, S. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.3.489 · Cited by 3,842 · see citing works
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327 · see citing works
REDFERN, W., Carlsson, L. G., DAVIS, A., LYNCH, W., MACKENZIE, I., PALETHORPE, S., Siegl, P. K. S., Strang, I., Sullivan, A. K., & WALLIS, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00846-5 · Cited by 1,535 · see citing works
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280 · see citing works
Self-citationRecent advances in three‐dimensional multicellular spheroid culture for biomedical research
Lin, R., & Chang, H. (2008) · Biotechnology Journal · doi:10.1002/biot.200700228 · Cited by 1,264 · see citing works
Hewitt, N. J., Gómez Lechón, M. J., Houston, J. B., Hallifax, D., Brown, H. S., Maurel, P., Kenna, J. G., Gustavsson, L., Lohmann, C., Skonberg, C., et al. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530601093489 · Cited by 735 · see citing works
Pharmacogenomics and Individualized Drug Therapy
Eichelbaum, M. F., Ingelman‐Sundberg, M., & Evans, W. E. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104724 · Cited by 719 · see citing works
Self-citationMcKenzie, R., Fried, M. W., Sallie, R., Conjeevaram, H., Di Bisceglie, A. M., Park, Y., Savarese, B., Kleiner, D., Tsokos, M., Luciano, C., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510263331702 · Cited by 616 · see citing works
Zonation of parenchymal and nonparenchymal metabolism in liver.
Jungermann, K., & Keitzmann, T. (1996) · Annual Review of Nutrition · doi:10.1146/annurev.nu.16.070196.001143 · Cited by 589 · see citing works
The determination and interpretation of the therapeutic index in drug development
Muller, P. Y., & Milton, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3801 · Cited by 566 · see citing works
Landry, J., Bernier, D., Ouellet, C., Goyette, R., & Marceau, N. (1985) · The Journal of Cell Biology · doi:10.1083/jcb.101.3.914 · Cited by 518 · see citing works
Abboud, G., & Kaplowitz, N. (2007) · Drug Safety · doi:10.2165/00002018-200730040-00001 · Cited by 480 · see citing works
LeCluyse, E. L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00135-x · Cited by 477 · see citing works
Rodríguez-Antona, C., Donato, M. T., Boobis, A., Edwards, R. J., Watts, P. S., Castell, J. V., & Gómez-Lechón, M.-J. (2002) · Xenobiotica · doi:10.1080/00498250210128675 · Cited by 420 · see citing works
Kaplowitz, N. (2004) · Clinical Infectious Diseases · doi:10.1086/381446 · Cited by 402 · see citing works
Multi-cell type human liver microtissues for hepatotoxicity testing
Messner, S., Agarkova, I., Moritz, W., & Kelm, J. M. (2013) · Archives of Toxicology · doi:10.1007/s00204-012-0968-2 · Cited by 319 · see citing works
Dynamic analysis of hepatoma spheroid formation: roles of E-cadherin and β1-integrin
Lin, R.-Z., Chou, L.-F., Chien, C.-C. M., & Chang, H.-Y. (2006) · Cell and Tissue Research · doi:10.1007/s00441-005-0148-2 · Cited by 305 · see citing works
Elaut, G., Henkens, T., Papeleu, P., Snykers, S., Vinken, M., Vanhaecke, T., & Rogiers, V. (2006) · Current Drug Metabolism · doi:10.2174/138920006778017759 · Cited by 292 · see citing works
Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing
Tostões, R. M., Leite, S. B., Serra, M., Jensen, J., Björquist, P., Carrondo, M. J. T., Brito, C., & Alves, P. M. (2011) · Hepatology · doi:10.1002/hep.24760 · Cited by 246 · see citing works
Feng, Z.-Q., Chu, X., Huang, N.-P., Wang, T., Wang, Y., Shi, X., Ding, Y., & Gu, Z.-Z. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.053 · Cited by 216 · see citing works
Competency of different cell models to predict human hepatotoxic drugs
Gómez-Lechón, M. J., Tolosa, L., Conde, I., & Donato, M. T. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.967680 · Cited by 199 · see citing works
Takayama, K., Morisaki, Y., Kuno, S., Nagamoto, Y., Harada, K., Furukawa, N., Ohtaka, M., Nishimura, K., Imagawa, K., Sakurai, F., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413481111 · Cited by 193 · see citing works
Drug metabolism in hepatocyte sandwich cultures of rats and humans
Kern, A., Bader, A., Pichlmayr, R., & Sewing, K. ‐. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00204-9 · Cited by 192 · see citing works
[42] Use of human hepatocytes to study P450 gene induction
Strom, S. C., Pisarov, L. A., Dorko, K., Thompson, M. T., Schuetz, J. D., & Schuetz, E. G. (1996) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(96)72044-x · Cited by 174 · see citing works
Shaw, P. J., Hopfensperger, M. J., Ganey, P. E., & Roth, R. A. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm218 · Cited by 161 · see citing works
Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells
Anthérieu, S., Azzi, P. B.-E., Dumont, J., Abdel‐Razzak, Z., Guguen‐Guillouzo, C., Fromenty, B., Robin, M., & Guillouzo, A. (2012) · Hepatology · doi:10.1002/hep.26160 · Cited by 146 · see citing works
Proteome-Wide Analyses of Human Hepatocytes During Differentiation and Dedifferentiation
Rowe, C., Gerrard, D. T., Jenkins, R., Berry, A., Durkin, K., Sundstrom, L., Goldring, C. E., Park, K. B., Kitteringham, N. R., Hanley, K. P., et al. (2013) · Hepatology · doi:10.1002/hep.26414 · Cited by 133 · see citing works
Self-citationVinci, B., Duret, C., Klieber, S., Gerbal‐Chaloin, S., Cunha, A. S., Laporte, S., Suc, B., Maurel, P., Ahluwalia, A. D., & Daujat‐Chavanieu, M. (2011) · Biotechnology Journal · doi:10.1002/biot.201000326 · Cited by 116 · see citing works
Microengineered Liver Tissues for Drug Testing
Khetani, S. R., Berger, D. R., Ballinger, K. R., Davidson, M. D., Lin, C., & Ware, B. R. (2015) · SLAS Technology · doi:10.1177/2211068214566939 · Cited by 116 · see citing works
Pharmacogenomic biomarkers: new tools in current and future drug therapy
Sim, S. C., & Ingelman‐Sundberg, M. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.11.008 · Cited by 102 · see citing works
Self-citationSison-Young, R. L. C., Mitsa, D., Jenkins, R. E., Mottram, D. R., Alexandre, E., Richert, L., Aerts, H., Weaver, R. J., Jones, R. P., Johann, E., et al. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv136 · Cited by 96 · see citing works
Self-citationGene expression profile in the regenerating rat liver after partial hepatectomy
Fukuhara, Y., Hirasawa, A., Li, X., Kawasaki, M., Fujino, M., Funeshima, N., Katsuma, S., Shiojima, S., Yamada, M., Okuyama, T., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00077-1 · Cited by 95 · see citing works
Metabolism and excretion of tolcapone, a novel inhibitor of catechol‐O‐methyltransferase
Jorga, K. M., Fotteler, B., Heizmann, P., et al. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00036.x · Cited by 92 · see citing works
Xu, D., Nishimura, T., Nishimura, S., Zhang, H., Zheng, M., Guo, Y., Masek, M., Michie, S. A., Glenn, J. S., & Peltz, G. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001628 · Cited by 86 · see citing works
Human CYP2C8 Is Post-Transcriptionally Regulated by MicroRNAs 103 and 107 in Human Liver
Zhang, S., Surapureddi, S., Coulter, S. J., Ferguson, S., & Goldstein, J. A. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.078386 · Cited by 74 · see citing works
Schutte, M. E., Fox, B. C., Baradez, M., Devonshire, A. S., Minguez, J., Bokhari, M., Przyborski, S. A., & Marshall, D. (2011) · Assay and Drug Development Technologies · doi:10.1089/adt.2011.0371 · Cited by 72 · see citing works
Walsh, J., Jenkins, R. E., Wong, M. H. L., Olayanju, A., Powell, H., Copple, I. M., O’Neill, P. M., Goldring, C. E., Kitteringham, N. R., & Park, B. K. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.05.007 · Cited by 71 · see citing works
Self-citationEvaluation of Human Hepatocytes Cultured by Three-dimensional Spheroid Systems for Drug Metabolism
Ohkura, T., Ohta, K., Nagao, T., Kusumoto, K., Koeda, A., Ueda, T., Jomura, T., Ikeya, T., Ozeki, E., Wada, K., et al. (2014) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-13-rg-105 · Cited by 71 · see citing works
Absolute bioavailability of amiodarone in normal subjects
Pourbaix, S., Berger, Y., Desager, J., et al. (1985) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1985.22 · Cited by 52 · see citing works
Fuhrmann, A., Lopes, P., Sereno, J., Pedro, J., Espinoza, D., Pereira, M. J., Reis, F., Eriksson, J. W., & Carvalho, E. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.020 · Cited by 43 · see citing works
In-depth physiological characterization of primary human hepatocytes in a 3D hollow-fiber bioreactor
Mueller, D., Tascher, G., Müller‐Vieira, U., Knobeloch, D., Nussler, A. K., Zeilinger, K., Heinzle, E., & Noor, F. (2011) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.418 · Cited by 43 · see citing works
Bioluminescence imaging allows measuring CD8 T cell function in the liver†
Stabenow, D., Frings, M. K., Trück, C., Gärtner, K., Förster, I., Kurts, C., Tüting, T., Odenthal, M., Dienes, H., Cederbrant, K., et al. (2010) · Hepatology · doi:10.1002/hep.23575 · Cited by 40 · see citing works
Bowsher, R. R., Compton, J., Kirkwood, J. A., Place, G. D., Jones, C. D., Mabry, T. E., Hyslop, D. L., Hatcher, B. L., & DESANTE, K. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.2134 · Cited by 22 · see citing works
Liguori, M. J., Ditewig, A. C., Maddox, J. F., Luyendyk, J. P., Lehman‐McKeeman, L. D., Nelson, D. M., Bhaskaran, V. M., Waring, J. F., Ganey, P. E., Roth, R. A., et al. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11114697 · Cited by 19 · see citing works
Gutierrez, M. M., Nicolas, L. B., Donazzolo, Y., & Dingemanse, J. (2013) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cp201806 · Cited by 15 · see citing works
INFLUENCE OF NUTRITIONAL FACTORS ON HATCHABILITY
Pearson, R. A. (1982) · Recent Advances in Animal Nutrition · doi:10.1016/b978-0-408-71015-2.50010-9 · Cited by 5 · see citing works
URINARY ??2 - MICROGLOBULIN IS A SENSITIVE AND SPECIFIC MARKER FOR ACUTE RENAL ALLOGRAFT REJECTION.
&NA; (2006) · Transplantation · doi:10.1097/00007890-200607152-01711 · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Three-Dimensional Cell Cultures in Drug Discovery and Development
Fang, Y., & Eglen, R. M. (2017) · SLAS Discovery · doi:10.1177/1087057117696795 · Cited by 849 · see citing works
Reproducing human and cross-species drug toxicities using a liver-chip
Jang, K.-J., Otieno, M. A., Ronxhi, J., Lim, H.-K., Ewart, L., Kodella, K. R., Petropolis, D. B., Kulkarni, G., Rubins, J. E., Conegliano, D., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aax5516 · Cited by 511 · see citing works
Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies
Edington, C. D., Chen, W. L. K., Geishecker, E., Kassis, T., Soenksen, L. R., Bhushan, B. M., Freake, D., Kirschner, J., Maass, C., Tsamandouras, N., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22749-0 · Cited by 487 · see citing works
Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury
Proctor, W. R., Foster, A. J., Vogt, J., Summers, C., Middleton, B., Pilling, M. A., Shienson, D., Kijanska, M., Ströbel, S., Kelm, J. M., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2002-1 · Cited by 328 · see citing works
“2016), and 3D spheroid cultures either as mono-culture or co-culture with hepatic non-parenchymal cells (NPC) (Bell et al. 2016; Messner et al. 2013).”
BackgroundResultInfluentialBell, C. C., Dankers, A. C. A., Lauschke, V. M., Sison-Young, R., Jenkins, R., Rowe, C., Goldring, C. E., Park, K., Regan, S. L., Walker, T., et al. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfx289 · Cited by 327 · see citing works
Self-citationBuilding consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids
Marsee, A., Roos, F. J. M., Verstegen, M. M. A., Marsee, A., Roos, F., Verstegen, M., Clevers, H., Vallier, L., Takebe, T., Huch, M., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.04.005 · Cited by 310 · see citing works
Self-citationBauer, S., Wennberg Huldt, C., Kanebratt, K. P., Durieux, I., Gunne, D., Andersson, S., Ewart, L., Haynes, W. G., Maschmeyer, I., Winter, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14815-w · Cited by 272 · see citing works
In Vitro Expansion of Primary Human Hepatocytes with Efficient Liver Repopulation Capacity
Zhang, K., Zhang, L., Liu, W., Ma, X., Cen, J., Sun, Z., Wang, C., Feng, S., Zhang, Z., Yue, L., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.10.018 · Cited by 252 · see citing works
3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection
Ortega-Prieto, A. M., Skelton, J. K., Wai, S. N., Large, E., Lussignol, M., Vizcay-Barrena, G., Hughes, D., Fleck, R. A., Thursz, M., Catanese, M. T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02969-8 · Cited by 236 · see citing works
Cell sources for <i>in vitro</i> human liver cell culture models
Zeilinger, K., Freyer, N., Damm, G., Seehofer, D., & Knöspel, F. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216657448 · Cited by 230 · see citing works
Costa, E. C., de Melo‐Diogo, D., Moreira, A. F., Carvalho, M. P., & Correia, I. J. (2018) · Biotechnology Journal · doi:10.1002/biot.201700417 · Cited by 224 · see citing works
A lung/liver-on-a-chip platform for acute and chronic toxicity studies
Bovard, D., Sandoz, A., Luettich, K., Frentzel, S., Iskandar, A., Marescotti, D., Trivedi, K., Guedj, E., Dutertre, Q., Peitsch, M. C., et al. (2018) · Lab on a Chip · doi:10.1039/c8lc01029c · Cited by 195 · see citing works
Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability
Hendriks, D. F. G., Fredriksson Puigvert, L., Messner, S., Mortiz, W., & Ingelman-Sundberg, M. (2016) · Scientific Reports · doi:10.1038/srep35434 · Cited by 156 · see citing works
Self-citationBaudy, A. R., Otieno, M. A., Hewitt, P., Gan, J., Roth, A., Keller, D., Sura, R., Van Vleet, T. R., & Proctor, W. R. (2020) · Lab on a Chip · doi:10.1039/c9lc00768g · Cited by 150 · see citing works
Ng, S. S., Saeb-Parsy, K., Blackford, S. J. I., Segal, J. M., Serra, M. P., Horcas-Lopez, M., No, D. Y., Mastoridis, S., Jassem, W., Frank, C. W., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.043 · Cited by 133 · see citing works
In Vitro Models for Non-Alcoholic Fatty Liver Disease: Emerging Platforms and Their Applications
Ramos, M. J., Bandiera, L., Menolascina, F., & Fallowfield, J. A. (2022) · iScience · doi:10.1016/j.isci.2021.103549 · Cited by 127 · see citing works
In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal
Soret, P.-A., Magusto, J., Housset, C., & Gautheron, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm10010036 · Cited by 121 · see citing works
Foster, A. J., Chouhan, B., Regan, S. L., Rollison, H., Amberntsson, S., Andersson, L. C., Srivastava, A., Darnell, M., Cairns, J., Lazic, S. E., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02427-4 · Cited by 117 · see citing works
Immune-mediated drug-induced liver injury: immunogenetics and experimental models
Gerussi, A., Natalini, A., Antonangeli, F., Mancuso, C., Agostinetto, E., Barisani, D., Di Rosa, F., Andrade, R., & Invernizzi, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094557 · Cited by 87 · see citing works
Grenier, J., Duval, H., Lv, P., Barou, F., Le Guilcher, C., Aid, R., David, B., & Letourneur, D. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.212973 · Cited by 72 · see citing works
Ekert, J. E., Deakyne, J., Pribul-Allen, P., Terry, R., Schofield, C., Jeong, C. G., Storey, J., Mohamet, L., Francis, J., Naidoo, A., et al. (2020) · SLAS DISCOVERY · doi:10.1177/2472555220923332 · Cited by 68 · see citing works
Primary Hepatocyte Isolation and Cultures: Technical Aspects, Challenges and Advancements
Kaur, I., Vasudevan, A., Rawal, P., Tripathi, D. M., Ramakrishna, S., Kaur, S., & Sarin, S. K. (2023) · Bioengineering · doi:10.3390/bioengineering10020131 · Cited by 64 · see citing works
Kim, T. Y., Kofron, C. M., King, M. E., Markes, A. R., Okundaye, A. O., Qu, Z., Mende, U., & Choi, B.-R. (2018) · PLOS ONE · doi:10.1371/journal.pone.0196714 · Cited by 57 · see citing works
Kammerer, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910214 · Cited by 59 · see citing works
Hendriks, D. F. G., Vorrink, S. U., Smutny, T., Sim, S. C., Nordling, Å., Ullah, S., Kumondai, M., Jones, B. C., Johansson, I., Andersson, T. B., et al. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1860 · Cited by 57 · see citing works
Self-citationLee, H.-J., Son, M. J., Ahn, J., Oh, S. J., Lee, M., Kim, A., Jeung, Y.-J., Kim, H.-G., Won, M., Lim, J. H., et al. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.09.041 · Cited by 47 · see citing works
Wesseler, M. F., Taebnia, N., Harrison, S., Youhanna, S., Preiss, L. C., Kemas, A. M., Vegvari, A., Mokry, J., Sullivan, G. J., Lauschke, V. M., et al. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.09.022 · Cited by 39 · see citing works
Self-citationDevelopment of an AI model for DILI-level prediction using liver organoid brightfield images
Tan, S., Ding, Y., Wang, W., Rao, J., Cheng, F., Zhang, Q., Xu, T., Hu, T., Hu, Q., Ye, Z., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08205-6 · Cited by 26 · see citing works
Liu, J., Li, R., Xue, R., Li, T., Leng, L., Wang, Y., Wang, J., Ma, J., Yan, J., Yan, F., et al. (2018) · Advanced Biosystems · doi:10.1002/adbi.201800110 · Cited by 23 · see citing works
Advancements in MAFLD Modeling with Human Cell and Organoid Models
Wang, S.-X., Yan, J.-S., & Chan, Y.-S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911850 · Cited by 22 · see citing works
Ex Vivo Tools and Models in MASLD Research
Velliou, R.-I., Giannousi, E., Ralliou, C., Kassi, E., & Chatzigeorgiou, A. (2024) · Cells · doi:10.3390/cells13221827 · Cited by 15 · see citing works
Multi-organ model assessment of neurotoxicity following exposure of liver spheroids to drugs
Wu, W., Anas, F., Koc, B., Tian, L., Hasselkus, R., Rezania, D., Sharareh, S., Farberov, L., Zlotnik, D., Alon, A., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118021 · Cited by 5 · see citing works
Lochman, L., Kahiya, E. T., Saade, B., Smutný, T., Tebbens, J. D., Pávek, P., & Bernhauerová, V. (2025) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1012886 · Cited by 3 · see citing works
Suali, L., Chia, Y., Rustin, C., Lem, F. F., Ching, X. J., Mansur, M. A. B., Henry, Z. A., Chan, M. K. S., Wong, M. B. F., & Pan, S. Y. (2026) · Biotechnic & Histochemistry · doi:10.1080/10520295.2026.2714776 · Cited by 1 · see citing works
“Furthermore, primary cells maintain essential tissue-level interactions, structural organization, and functional stability, which are critical for modeling drug penetration, systemic toxicity, and tissue-specific response (Bell et al. 2016).”
Ferret-Miñana, A., Alcaraz, E., Horrillo, R., Ramón-Azcón, J., & De Chiara, F. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1798323
The Hepatocyte Expansion Paradox: A Review of In Vitro Challenges and Advances
Kolahdouzmohammadi, M., Tjandra, N., Wu, K., Nikoumaram, R., & Oldani, G. (2026) · Cells · doi:10.3390/cells15161465
“Multiple comparative studies indicate that spheroid cultures sustain elevated liver-specific functions, such as albumin secretion, urea production, and drug-metabolizing enzyme activity, while simultaneously demonstrating enhanced sensitivity to hepatotoxic compounds and a longer lifespan [26,27].”
- Authors
- Bell, C. C., Hendriks, D. F. G., Moro, S. M. L., Ellis, E., Walsh, J., Renblom, A., Fredriksson Puigvert, L., Dankers, A. C. A., Jacobs, F., Snoeys, J., Sison-Young, R. L., Jenkins, R. E., Nordling, Å., Mkrtchian, S., Park, B. K., Kitteringham, N. R., Goldring, C. E. P., Lauschke, V. M., & Ingelman-Sundberg, M.
- Affiliations
- Karolinska Institutet (SE)
- Karolinska University Hospital (SE)
- University of Liverpool (GB)
- Janssen (Belgium) (BE)
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-05-04
- Volume
- 6
- Issue
- 1
- Pages
- 25187-25187
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4855186
- OpenAlex
- W2345415005
- Cited by
- 739
- References
- 47
- Citations by year
- 2026: 67 · 2025: 75 · 2024: 60 · 2023: 69 · 2022: 73 · 2021: 76 · 2020: 87 · 2019: 74 · 2018: 90 · 2017: 51 · 2016: 15
- FWCI
- 95.83
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- European Commission (115336)
- Vetenskapsrådet
- Technische Universität München
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Keywords
- primary human hepatocytes, hepatocyte spheroids, drug-induced liver injury, 3D cell culture, serum-free culture, hepatotoxicity, FIAU, chronic toxicity, cholestasis, steatosis, viral hepatitis, liver disease modeling, proteomics, interindividual variability
- MeSH terms
- Proof of Concept Study, Arabinofuranosyluracil, Cells, Cultured, Humans, Models, Biological, Spheroids, Cellular, Proteome, Hepatocytes, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review